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Summary 
Lactose is a common excipient in Dry Powder Inhaler (DPI) formulations, used as a carrier for the micronized drug 
particles. The presence of intrinsic lactose fines in the formulation influences its performance and their role and 
interactions between the lactose carrier and the micronized drug is still not fully understood. As a first step towards 
this investigation, “clean” lactose, with removed fines, was produced via wet decantation. Ethanol and isopropyl 
alcohol have been used in wet decantation, successfully removing lactose fines from the surface of the coarse 
particles. Differential Scanning Calorimetry (DSC) was employed to show that the powders maintained their 
crystalline character. Scanning Electron Microscopy (SEM) showed tomahawk-shaped particles in all the powders 
and some surface alteration occurring after decantation. An airflow titration method using laser diffraction (LDA) 
allowed the estimation of the removal of fines as well as the particle size distributions, while the non-polar and the 
polar components of the surface energy of the powders were calculated via Inverse Gas Chromatography-Surface 
Energy Analysis (iGC-SEA). As both solvents successfully removed fines, we propose the addition of isopropyl 
alcohol in the list of organic solvents suitable for this purpose. 
Key Message 
Removal of intrinsic fines from inhalation grade lactose monohydrate can be achieved via wet decantation, using 
isopropyl alcohol instead of ethanol.  
Introduction 
Lactose is used as an excipient in a plethora of inhaled formulations; its role is that of a coarse carrier particle 
bulking agent where the micronized drug particles (usually in the range of 1-5 μm) are attached [1]. The 
physicochemical properties of lactose, as well as the addition, or absence, of lactose fines has been shown to affect 
the fine particle fraction of a formulation and as such, its success or failure.[2–4]. However, the underlying interactions 
that take place between the carrier particles and the drug fines are still not fully understood. In an attempt to shed 
light in these complex interactions, a step-by-step process has been proposed; clean coarse lactose particles can 
be prepared via wet decantation [4], in order to produce a “clean” platform where the addition of lactose fines can 
be achieved in a controlled manner, followed by the addition of the micronized drug.  
In this present work we focus on the solvent selection for wet decantation; although Ethanol has been used before 
for the surface modification of lactose, the use of other organic solvents have not been reported. We investigated 
the use of isopropyl alcohol, as well as the established ethanol, in wet-decantation and characterised the “clean” 
lactose powders produced via Laser Diffraction Analysis (LDA), Scanning Electron Microscopy (SEM), Differential 
Scanning Calorimetry (DSC) and Inverse Gas Chromatography- Surface Energy Analysis (iGC-SEA).  
Materials and Methods 
Inhalation grade lactose monohydrate, namely Lactohale 100 (sieved) and Lactohale 200 (milled), was provided by 
DFE Pharma (Goch, Germany). Organic solvents (Isopropyl Alcohol and Absolute Ethanol) were purchased from 
Fischer Scientific (Loughborough, UK).  
Wet decantation was adjusted following the protocol proposed by Islam et al.[4]. Approximately 20 g of lactose was 
dispersed in 500 mL of solvent (ethanol, isopropyl alcohol) in a conical flask. During the first run, the flask was 
sonicated for 3 mins to make a homogeneous suspension. The suspension was then allowed to settle for 15 min. 
The supernatant liquid was decanted through grade 1 filter paper, with extra care to minimise the disturbance on 
the precipitated powder at the lower part of the suspension. The supernatant was filtered and recycled back into 
the flask as a saturated solvent. The flask was then vigorously mixed (manually) for 2 min prior to the next settling 
run. The process was repeated until the supernatant liquid was clear. The decantation process was done with extra 
care to have minimal disturbance on lower parts of the suspension and prevent the removal of larger particles. In 
the final step the powders were wet-sieved (63 μm) and allowed to air-dry for 24 h.  
Particle morphology was investigated via Scanning Electron Microscopy (SEM). The powders were deposited onto 
adhesive carbon tabs (Agar Scientific G3357N), which were pre-mounted onto aluminium stubs (Agar Scientific 
JEOL stubs G306). Samples were then sputter coated with gold for 1 minute to achieve a thickness of around 30 
nm (Quorum SC7620). The images were acquired using a JEOL 5700 scanning electron microscope, operated at 
20kV, and a working distance of 10 mm. 
Differential Scanning Calorimetry (DSC) experiments were conducted in a DSC 200 (TA Instruments), calibrated 
with Indium as a reference material, at a heating rate of 10 oC/min. In all measurements nitrogen was used as the 
purge gas, flowing at a rate of 50 ml/min. Tzero sample pans with a pinhole lid were used for all the samples.  
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Particle size measurements were performed on a Sympatec HELOS/RODOS Laser Diffraction (LDA) unit, using 
the ASPIROS dispersing system (dispersing aperture diameter 4mm, feed velocity 25 mm/s) (Sympatec GmbH, 
Clausthal-Zellerfel, Germany). The R5 lens (measuring range 4.5–875 μm) was fitted for the measurements. 
Powder was filled into the ASPIROS glass vials and was dispersed via vacuum suction. Airflow titration 
measurements were performed following a previously established protocol [5]. The primary pressure (PP) was 
manually set using the adjustment valve in the range 0.2–5.0 Bar and three measurements were taken at each 
pressure setting using freshly loaded powder. Particle size distributions were calculated using the Fraunhofer theory 
and were analysed in WINDOX 5.3.1.0 software, while further analysis was performed in MATLAB. Particle size 
measurements for a complete airflow titration curve were conducted on a single day.  
Specific surface area (SSABET) and surface energy (SE) analysis were conducted using an Inverse Gas 
Chromatography Surface Energy Analyser (iGC-SEA, Surface Measurement Systems Ltd, UK). Approximately 1 g 
for the lactose was packed into silanised iGC glass columns (internal diameter 4mm). Prior to any measurements, 
the columns were conditioned using helium carrier gas at 10 scc/min for 2 h at 30 oC and 0% RH. Methane gas was 
injected at the start and the end of the experiments for the dead volume calculation. SSABET was calculated via the 
Brunauer-Emmett-Teller (BET) theory, based on the n-octane adsorption isotherm data [6]. For the surface energy, 
the columns were equilibrated as mentioned above. Non-polar probes (n-undecane, n-decane, n-nonane, n-octane 
and n-heptane) and polar probes (dichloromethane, ethyl acetate, ethanol, acetone and acetonitrile) were injected 
in the column at a range of surface coverages (n/nm). Following an analysis method previously reported[5], the 
dispersive (γd, non-polar) and acid-base (γab, polar) components of the surface energy were calculated using the 
Dorris-Gray method. All measurements were made in triplicate.  
Results 
Due to the different production method, milled Lactohale 200 has a higher percentage of fines, as can been seen 
in Figure 1. After wet decantation the surface fines have clearly been reduced, and a smoother surface can be seen 
in the larger particles that maintain their tomahawk shape. Solid bridging was observed in the initial wet decantation 
trials (data not shown), however it was significantly reduced thanks to the wet-sieving final step.  
 
Figure 1 - SEM images of Lactohale 100 (top row left), and Lactohale 200 (bottom row left) decanted with isopropyl 
alcohol (IPA- middle) with ethanol (right) (x500 magnification). Some surface alteration can be seen using IPA and ethanol 
but they have both succeeded in the removal of the fines.  
The solid-state of the powders was evaluated via DSC (Figure 2). The thermographs are in accordance with the 
expected α-lactose monohydrate behaviour, exhibiting an endothermic dehydration peak at 147 oC while the melting 
endotherm commenced at about 207oC [7].  
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Figure 2 – DSC thermographs of the raw (blue line) Lactohale 100 (left) and Lactohale 200 (right), decanted with ethanol 
(light brown line) and isopropyl alcohol (black line). The powders exhibit the same thermal behaviour indicating that their 
crystalline state has not been altered.  
LDA measurements were conducted to investigate the particle size distribution of the powders under flow (Figure 
3, top row). D10 was found to be 55.1 ± 1 for Lactohale 100, 47.9 ± 1.1 for Lactohale 100 – Ethanol, and 66.2 ± 2.4 
for Lactohale 100 – IPA. The same trend was observed for the Lactohale 200 powders as well with D10 = 13.2 ± 0.8 
for Lactohale 200, 19.7 ± 0.5 for Lactohale 200 – Ethanol and 28.2 ± 0.7 for Lactohale 200 – IPA. In order to have 
a better understanding of the removal of fines, D2, reporting the particles  in the lower 2% of the PSD was measured 
in the whole pressure range (Figure 3, bottom row). As the pressure increases, D2 decreases, as any smaller 
particles, loosely bound to the surface will de-agglomerate a result consistent with literature[5,8]. However, IPA has 
in both cases, the highest D2, suggesting a better removal of fines.  
 
Figure 3 – Top row: Particle Size Distribution of the raw materials and the decanted powders when dispersed at 2.0 bar 
primary pressure. Bottom row: Airflow titration measurements in the range 0.2-5.0 bar, reporting the amount of particles 
smaller than the 2% of the distribution (D2), for Lactohale 100 (left) and Lactohale 200 (right). In both cases, the IPA 
treated lactose (light brown) has the highest D2, indicating the highest removal of fines. (70.3% for Lactohale 100 and 
84.2% for Lactohale 200). 
Surface Energy (SE) analysis was conducted for the Lactohale 200 powders using iGC (Table 1). An increase in 
the BETSSA of the decanted powders was observed; this could be attributed to surface modification as an effect of 
the solvents. The highest contribution in the total surface energy is through dispersive forces (45.2 ± 0.2 for 
Lactohale 200) as has been reported previously[9]. Wet decanted powders exhibit lower SE values; 39.2 ± 0.3 for 
Lactohale 200-Ethanol and 41.4 ± 0.1 for Lactohale 200 – IPA. The reduction in the SE indicates the successful 
removal of the high-energy fines from the surface.  
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Table 1 – Surface Energy measurements via Inverse Gas Chromatograph (iGC-SEA) at 3% surface coverage (n=3, ± SD) 
 Lactohale 200 Lactohale 200 Ethanol Lactohale 200 Isopropyl Alcohol 
BETSSA (m2/g) 0.3071 ± 0.0008 0.391 ± 0.003 0.3703 ± 0.0008 
γd (mJ/m2) 45.2 ± 0.2 39.2 ± 0.3 41.4 ± 0.1  
γab (mJ/m2) 6.2 ± 0.1 2.59 ± 0.06 3.73 ± 0.05 
Discussion 
It has been shown in the past that addition of fines in coarse lactose samples results in an overall increase in surface 
energy [10]. In a similar note, the removal of fines via wet decantation as presented in this work, has resulted in the 
decrease of the surface energy of the coarse lactose particles. The lower SE of the ethanol-treated lactose indicates 
that fewer high-energy fines are present in the powder i.e. a better removal of fines in comparison to IPA. This 
comes in contradiction with what was observed via Laser Diffraction, where the D2 values of IPA-treated lactose 
were consistently higher than the others. This could be explained by the remaining fines in the IPA-treated powders 
not being as readily dispersed under the airflow as the ethanol ones. An alternative explanation is the potential for 
surface-modification (e.g. localized surface etching and/or dissolution) due to dispersion in IPA solvent. The latter 
issue is currently being addressed through further surface characterization studies. The importance of iGC-SEA is 
highlighted, as it can facilitate the understanding of the absence/presence of fines in a formulation. Nevertheless, 
IPA has demonstrated a similar behaviour to ethanol, and is recommended from the authors as a second solvent 
of choice for wet-decantation.  
Conclusion 
This study investigated the use of isopropyl alcohol (IPA) instead of ethanol in wet decantation for the removal of 
intrinsic lactose fines. Both solvents have successfully removed lactose fines and in doing so a decrease in the 
Surface Energy of the lactose carriers was observed. Although LDA measurements suggested that IPA had 
removed more fines than ethanol, the significant difference in the Surface Energy measurements between the two 
implies that ethanol still removed more fines, while IPA-remaining fines were more strongly adhering to the particles’ 
surface, and were not as easily dispersed under the airflow. 
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